Introduction
Many patients with cirrhosis experience hepatic encephalopathy due to decreased function of the diseased liver and shunting of portal blood around the liver into the systemic circulation. Accumulation of nitrogen-containing compounds, including ammonia, in the systemic circulation is thought to be the etiology of the resulting encephalopathy [1] . Portosystemic shunts may also arise in non-cirrhotic patients as well. These shunts may be the result of congenital anomalies, trauma, or intentional/iatrogenic complications from surgery or other procedures [2] . These portosystemic shunts can cause a similar type of encephalopathy even without overt liver disease.
The natural history of portosystemic shunts after liver transplant is not well documented, but prevailing thought is that most of these shunts close or quickly become clinically irrelevant. Clinical problems from ascites, encephalopathy, and varices generally resolve soon after transplant without specific intervention.
These patients had well-documented hepatic encephalopathy due to persistent portosystemic shunts after liver transplant. There are only two other cases of this phenomenon reported in the literature and one of these involved a 23-year-old recipient of only a left lobe [3, 4] . Herein described are two patients who received whole livers from deceased donors. Both have been successfully treated, one by closing the shunt with intravascular embolization and the other with maintenance lactulose and rifaximin.
Case 1
A 45-year-old Caucasian female had an orthotopic liver transplant in late May 2007 for decompensated cirrhosis due to chronic hepatitis C. The patient had an uncomplicated operation and immediate post-operative course and was discharged from the hospital 13 days after transplant. There were no issues with hepatic steatosis in the graft, post-operative biliary or hepatic artery complications. The cold ischemia time was 5 h 40 min. Prior to transplant, the patient had difficulty with hepatic encephalopathy, ascites, gastroesophageal varices, and peripheral edema. The MELD score was 31 at transplant. The post-transplant course was otherwise unremarkable without episodes of significant rejection or disease recurrence.
In September of 2007, 4 months post-transplant, the patient was readmitted to the hospital for altered mental status. There was no clear precipitating reason for the altered mental status according to the patient's family. During that admission, the evaluation included normal liver enzymes, bilirubin, complete blood count with normal platelet count, serum chemistries, and negative blood and viral cultures, negative urine toxicology screen. The graft's synthetic function was good with an INR of 1.2. Imaging consisted of a normal head CT and a normal liver transplant ultrasound that showed no evidence of nodularity or morphologic abnormalities. However, the venous ammonia level was 65 lmol/l (normal 9-33). The patient responded to lactulose and her mental status returned to her normal baseline.
For the next 3 months, the patient remained in her usual state of good health. An upper endoscopy showed no varices and mild portal hypertensive gastropathy. The patient was seen in the clinic in late December 2007 and she was doing quite well. Three days after the clinic visit, however, the patient became combative and irrational. Friends and family stated that there were no clear precipitating factors leading to the decline in her mental status. The patient was admitted to an outside hospital and then transferred to UNC. Again, other than an elevated venous ammonia level of 165 lmol/l, the evaluation was unrevealing. Again, there was a rapid clinical response to lactulose with a corresponding drop in ammonia to 19 lmol/l. A repeat liver transplant ultrasound showed diminished portal vein velocities, but was otherwise normal. At this point, the diagnosis of a persistent porto-systemic shunt was entertained.
The patient underwent an abdominal CT scan ( Fig. 1 ), which was without any architectural changes in the liver but was notable for an inferior mesenteric vein to left renal vein shunt via a dilated left gonadal vein. The liver volume to body mass ratio was 1.84%. Subsequently, the patient had a trans-hepatic portogram with embolization of the inferior mesenteric vein-gonadal vein collateral (Figs. 2, 3,  4) . Afterwards, Doppler ultrasound of the hepatic vasculature showed improved flow within the portal vein.
In over 12 months of follow-up, the patient has done well and has not required any lactulose, nor has she had any further episodes of hepatic encephalopathy or altered mental status.
Case 2
A 55-year-old male was transplanted in 1997 for cryptogenic cirrhosis. There were no issues with hepatic steatosis in the graft, post-operative biliary, or hepatic artery complications. For more than 10 years, the patient had an uncomplicated post-operative course with the exception of mild chronic lower extremity edema, which was managed with diuretics.
Overall, the patient maintained his state of good health until January 2008 when he was admitted to his local hospital with an altered mental status. There were no clear precipitating events that lead to his illness. Liver function tests, chemistries, complete blood count including platelet count, toxicology screen, and cultures were all normal. His evaluation was unrevealing except for an elevated ammonia level. His graft was otherwise well functioning with an albumin of 3.7 g/dl and INR of 1.1. A liver biopsy showed mild periportalcholestasis without duct loss, mild biliary atrophic changes but was negative for acute rejection or viral cytopathic effect. There was no advanced fibrosis or cirrhosis. After administration of lactulose, his ammonia level and mental status improved.
In April of 2008, the patient returned to a local hospital with sudden onset altered mental status, and again, the evaluation was normal with the exception of an ammonia level. The graft function was preserved with an albumin of 3.8 g/dl and an INR of 1.1. Liver function tests were all normal. The patient was treated with lactulose with subsequent improvement in mental status and a fall in ammonia levels within 24 h. The patient and friends describe these episodes as clinically identical to his pretransplant hepatic encephalopathy and without obvious precipitating factors. Upon discharge, he was put on a maintenance lactulose regimen.
On return to UNC, a diagnosis of a spontaneous or persistent portosystemic shunt was entertained. A CT scan was performed (Fig. 5 ) that showed dilated left renal vein, splenic veins, splenic varices, and a splenorenal shunt. The liver volume to body mass ratio was 0.94%. There was also sluggish flow in the portal vein on Doppler ultrasound. At this point, arrangements were made to close the shunt via interventional radiology coil embolization. On the day of the procedure, however, the patient changed his mind and declined the intervention and elected to remain on maintenance lactulose. The patient had some mild renal insufficiency (serum creatinine 1.39, creatinine clearance 53.05 ml/min/m 2 ) due to chronic calcinurin-inhibitor use and was concerned about the risk of IV contrast renal toxicity. Rifaximin was added to the patient's medical regimen in June 2008; since then, the patient has been symptom free.
Discussion
The prevailing opinion is that portosystemic shunts should close once portal hypertension resolves after transplant. However, the evidence for decreased portal hypertension and shunt closure in adults is limited. Yanaga et al. observed the reversal of splenomegaly post transplant [5] . A study by Ling et al. [6] regarding children who Conversely, there are studies that suggest persistence of portal hypertension and portosystemic collaterals. Chezmar et al. [7] , showed persistence of portosystemic collaterals by CT scan in 74 and 64% of patients at 6 months and 1 year post-transplant. One patient had multiple collaterals 4 years after transplant. Dupuy et al. [8] found 29% of patients who had a CT scan performed up to 2 years after transplant manifested splenomegaly. These studies were based on radiologic findings that were presumably subclinical.
Hyperdynamic systemic circulation post-transplant also hints at persistent shunting. Hadengue et al. [9] , studied systemic and splanchnic hemodynamics in seventeen patients before and after liver transplant and compared these patients to controls with normal liver architecture. Cardiac index, azagous blood flow and hepatic blood flow remained elevated after transplant even in the setting of normal portosystemic pressure gradients.
Post-transplant portal hypertension may be episodic as well and correlate with inflammation such as during acute rejection or ischemia. De Carlis et al. [10] found that patients with post-transplant portosystemic shunts had a significantly higher AST level during episodes of rejection compared to post transplant patients without a portosystemic shunt. They concluded that the height of the AST elevation was due to a ''steal'' phenomenon during times of increased vascular resistance in the graft more so than the rejection itself.
Portosystemic shunts and portal hypertension may persist in some patients, even years after transplant. The natural history and significance of persistent shunting is unclear. The rarity of such shunt-related encephalopathy is likely due to well-functioning grafted livers. Nevertheless, portosystemic shunts in the non-cirrhotic setting (trauma, iatrogenic) leading to encephalopathy is well described [2] .
These patients had otherwise well-functioning grafts. Although the first patient did not have a liver biopsy, rapidly recurrent hepatitis C is unlikely. The patient had no significant elevations in liver enzymes. In particular, there was no cholestatic enzyme pattern suggestive of cholestatic recurrent hepatitis C. Synthetic function and platelet counts were intact and there were no varices on endoscopy. Most of all, the patient remains well with excellent functional status without anti-viral therapy. If there was severe and rapid recurrence of hepatitis C with cirrhosis within just 4 months of transplant, mere embolization of a shunt would not be expected to stabilize such a rapid decline in graft status. The patient should be having other manifestations or biochemical evidence of liver failure by now. Detailed MRI imaging studies did not suggest graft outflow obstruction and there were no clinical signs of right heart failure.
In the second case, the presentation was several years after transplant. A liver biopsy confirmed no advanced fibrosis. It remains puzzling as to why the second patient presented so late, but gradual shifting of portal flow to the shunt is speculated. A spontaneous shunt is also a possibility, but equally vexing given the lack of cirrhosis or portal hypertension.
It is interesting to note that both patients had relatively low estimated liver to body mass ratio (1.84% for patient 1 and 0.94% for patient 2). Whether this contributed to the persistence of shunting is unclear. While low, the percentages are still well within an acceptable range for transplant. The acceptable lowest limits are seen in adult living donor liver transplant where only right lobe is grafted is 0.8-0.6% [11] .
Both patients developed recurrence of their hepatic encephalopathy documented by elevated ammonia levels and response to standard medical therapies. One of the only other cases in the literature involved a 23-year-old who received a left lobe from a living donor. Smaller graft volume may have contributed to persistence of shunting and encephalopathy in that case. These cases are among the first involving a whole liver graft from a deceased donor and demonstrate successful treatment by intravascular embolization or medical therapy.
